2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regimen. For the detailed information of Dalbavancin, the solubility of Dalbavancin in water, the solubility of Dalbavancin in DMSO, the solubility of Dalbavancin in PBS buffer, the animal experiment（test） (test) of Dalbavancin, the cell expriment (test) of Dalbavancin, the in vivo, in vitro and clinical trial test of Dalbavancin, the EC50, IC50,and Affinity of Dalbavancin,, please contact DC Chemicals.
